ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
58,505.45
0.46%
S&P 500
5,041.16
0.45%
Dow Jones
38,039.26
0.36%
US Dollar vs Yen
154.724
-0.64%
Brent Oil
83.655
0.14%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Inovio Pharmaceuticals Inc New (INO)

  7. Inovio Pharmaceuticals Inc New (INO) ニュース

INO Inovio Pharmaceuticals Inc New

12.0392
0.4492 (3.88%)
プレマーケット
最終更新日： 22:21:27
15分遅延
名称 銘柄コード 市場 種別
Inovio Pharmaceuticals Inc New INO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.4492 3.88% 12.0392 22:21:27
始値 安値 高値 終値 前日終値
11.59
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0121:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
2024/4/2921:00PRNUSINOVIO to Participate in Upcoming Investor Conferences in..
2024/4/1607:39PRNUSINOVIO Announces Pricing of Approximately $36 Million..
2024/3/2707:28PRNUSINOVIO to Participate in The Citizens JMP Novel Therapeutics..
2024/3/0706:05PRNUSINOVIO Reports Fourth Quarter and Full Year 2023 Financial..
2024/3/0621:00PRNUSGeneos Therapeutics to Present New Clinical Data on..
2024/3/0620:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
2024/2/2122:00PRNUSINOVIO to Report Fourth Quarter and Year-End 2023 Financial..
2024/2/0801:46PRNUSINOVIO to Present at the Oppenheimer 34th Annual Healthcare..
2024/2/0222:00PRNUSINOVIO Reports Inducement Grant Under Inducement Plan
2024/2/0114:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/2706:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
2024/1/2606:02EDGAR2Form 8-K - Current report
2024/1/2322:00PRNUSINOVIO Announces Effective Date of 1-for-12 Reverse Stock..
2024/1/2222:00PRNUSINOVIO to Participate in Virtual Fireside Chat on the..
2024/1/1307:27EDGAR2Form 8-K - Current report
2024/1/0422:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
2024/1/0322:00PRNUSINOVIO Plans to Submit a BLA for INO-3107 as a Potential..
2023/11/2906:05EDGAR2Form DEF 14A - Other definitive proxy statements
2023/11/1806:00EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/1006:35EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1006:15EDGAR2Form 8-K - Current report
2023/11/1006:05PRNUSINOVIO Reports Third Quarter 2023 Financial Results and..
2023/11/1006:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:01EDGAR2Form 8-K - Current report
2023/11/0121:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
2023/10/2621:00PRNUSINOVIO to Report Third Quarter 2023 Financial Results on..
2023/10/1105:00EDGAR2Form 8-K - Current report
2023/10/1023:51DJNInovio Shares Rise 8% After FDA Feedback for INO-3107
2023/10/1021:00PRNUSINOVIO Receives FDA Feedback that Data from Completed Phase..
2023/9/2808:39PRNUSGeneos Therapeutics Closes its Series A3 Financing With..
2023/9/0721:00PRNUSINOVIO Announces U.S. FDA Breakthrough Therapy Designation..
2023/8/2921:00PRNUSINOVIO to Present at the H.C. Wainwright 25th Annual Global..
2023/8/1005:23EDGAR2Form 8-K - Current report
2023/8/1005:05PRNUSINOVIO Announces Second Quarter 2023 Financial Results and..
2023/8/1005:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0421:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
2023/8/0110:43EDGAR2Form 8-K - Current report
2023/7/2622:32PRNUSINOVIO to Report Second Quarter 2023 Financial Results on..
2023/7/0805:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/7/0406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2405:10GLOBEINOVIO Announces Notice of Pendency and Proposed Settlement..
2023/6/0121:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
2023/5/2521:00PRNUSINOVIO to Present at the 2023 Jefferies Healthcare..
2023/5/2405:13PRNUSINOVIO Announces Orphan Drug Designation for INO-3107 for..
2023/5/1105:05PRNUSINOVIO Reports First Quarter 2023 Financial Results and..
2023/5/0821:00PRNUSNew Data from Phase 1/2 Trial of INO-3107 for the Treatment..
2023/5/0521:00PRNUSINOVIO to Present at the 2023 RBC Capital Markets Global..

最近閲覧した銘柄

NASDAQ
INO
Inovio Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有